Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
IDT Biologika
Sort By
Newest First
1 / 1
Vaccine and Cell & Gene Therapies
Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics
lrike Fiedler Dr. Rer. Nat.
IDT Biologika
PAO-04-022-CL-02
Apr 13, 2022
Viral Vectors
Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology
Heidi Trusheim, Ph.D.
IDT Biologika
PAO-02-022-CL-09
Mar 12, 2022
Oncolytic Viruses
Best Practices For Oncolytic Virus Design, Development, and Manufacturing
Heidi Trusheim, Ph.D.; Trevor Broadt
IDT Biologika
PAO-02-022-CL-17
Mar 09, 2022
IDT Biologika
Scale-Up Collaboration
IDT Biologika Collaborates with Exothera to Push Forward the Scale-Up of Viral Vaccines
IDT Biologika
PR-M03-22-01
Mar 01, 2022
Vaccines
100 Years in Vaccines and Looking Toward the Future
IDT Biologika
PAO-01-22-R250-13
Jan 28, 2022
IDT Biologika
Vaccines
IDT Biologika is Increasing its Production Capacity of Vaccines – Saxony-Anhalt's Prime Minister Reiner Haseloff Visited the New Facilities
IDT Biologika
PR-M01-22-13
Jan 20, 2022
2021 Roundup: The Year of Cell and Gene Therapy
David Alvaro, Ph.D.
Pharma's Almanac
PA734
Dec 20, 2021
IDT Biologika
Collaboration
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001
IDT Biologika
PR-M12-21-02
Dec 15, 2021
Viral Vaccines
Viral Vectors, Vaccines — A New Era Of Collaborative Design
Andreas Neubert, Ph.D.
IDT Biologika
PAO-10-21-CL-17
Nov 08, 2021
Vaccines
IDT Biologika Celebrates 100 Years of Successful Vaccine Development and U.S. Expansion
Ashik Pavagadhi
IDT Biologika
PAO-10-21-CL-07-793
Oct 15, 2021
1 / 1
